Guadalupe Sabio Explained

Guadalupe Sabio
Birth Date:4 June 1977
Birth Place:Badajoz
Nationality:Spanish
Alma Mater:University of Extremadura
University of Dundee
Workplaces:Spanish National Cardiovascular Research Centre
Howard Hughes Medical Institute
Website:Sabio Lab

Guadalupe Sabio Buzo (born 4 June 1977) is a Spanish scientist and Professor at the Spanish National Cardiovascular Research Centre, which is part of the Carlos III Health Institute. Her research considers stress-activated kinases and the development of diseases associated with obesity. She was awarded the Princess of Girona Foundation Scientist Prize in 2012 and selected as one of the Top 100 Women Leaders in Spain in 2017.

Early life and education

Sabio was born in Badajoz in 1977. She attended the Colegio del Santo Ángel and the Institute of San Fernando.[1] She studied veterinary sciences at the University of Extremadura, and graduated in 2000 with an extraordinary award.[2] She has said that she chose to study veterinary science as she liked animals very much, and that this could help her understand the origins of diseases. She moved to the United Kingdom for her doctoral studies, where she joined the University of Dundee as a Medical Research Council European graduate student. She completed her doctorate on p38 delta kinases in 2005.[3] Whilst her PhD had taught her how to research in vitro, Sabio was keen to translate her research into mouse models. She joined the research group of Roger Davis at the Howard Hughes Medical Institute where she studied the impact of stress on kinases proteins. In 2009 she was awarded Santiago Ramón y Cajal funding to join a biotechnology laboratory in Spain.

Research and career

Sabio joined the Spanish National Cardiovascular Research Centre in 2011.[4] Sabio is investigating the molecular mechanisms that are associated with obesity, and how they can predispose patients to other conditions such as hepatocellular carcinoma.[5] [6] Hepatocellular carcinoma is a type of liver carcinoma, and the second most common cause of cancer-related deaths. Whilst there is chemotherapy available, it can only increase a patient's life by three months. Sabio researches p38gamma, a kinase protein that is expressed excessively in patients with hepatocellular carcinoma, and whether inhibition of this protein could reduce the cancer. She is developing drugs that inhibit p38gamma for the treatment of liver cancer.[7] She has also investigated the C-Jun N-terminal kinases (JNK) protein, which is known to control obesity.

She believes that obesity will be a major challenge for future generations, and it should be taken as seriously as smoking.[8] [9] By considering fat, adipose tissue, as an endocrine organ she believes people will think more carefully about how to care for it.[10] She believes that the best antidotes to obesity are exercise and diet.[11] In 2017 Sabio was inducted into the European Molecular Biology Organization.[12]

Sabio has been involved in several initiatives to promote women in science.[13] She has called for more research into the symptoms of disease experienced by women.[5]

Selected publications

Awards and honours

Notes and References

  1. Web site: Vencer la obesidad puede ser más difícil que vencer el cáncer. 2016-12-18. Hoy. es-ES. 2019-11-03.
  2. Web site: Jurado-Dra. Guadalupe Sabio Buzo. Premios a la investigación FJS. es-ES. 2019-11-04.
  3. Web site: Alumni Interview Guadalupe Sabio. MRC. 2019-11-04.
  4. Web site: La científica Guadalupe Sabio: Estar obeso es jugar a la ruleta rusa. EFE. eldiario.es. es. 2019-11-04.
  5. Web site: Investigar con perspectiva de género es básico para salvar la vida de las mujeres y prevenir enfermedades. www.publico.es. 2019-11-03.
  6. Web site: Guadalupe Sabio defiende el papel de la grasa como órgano endocrino. ELDIAdigital. eldiadigital es. eldiadigital.es Periódico de Castilla-La Mancha. es. 2019-11-03.
  7. Web site: Descubren una nueva diana terapéutica para tratar el cáncer de hígado. 2019-04-10. Red Leonardo. es. 2019-11-03.
  8. Web site: Guadalupe Sabio: "Hacen falta medidas más drásticas contra la obesidad". 2019-10-27. ELMUNDO. es. 2019-11-03.
  9. Web site: Peligros sobre la obesidad. 2019-03-17. La Vanguardia. 2019-11-04.
  10. Web site: La investigadora del CNIC Guadalupe Sabio defiende en la UCLM el papel de la grasa como órgano endocrino. Mancha. Universidad de Castilla-La. Universidad de Castilla - La Mancha. 2019-11-04.
  11. News: Hay muchas farmacéuticas en busca de la pastilla contra la obesidad. Pero aún no existe nada efectivo. Moreno. Ana García. 2019-08-06. El País. 2019-11-04. es. 1134-6582.
  12. Web site: Guadalupe Sabio entra a formar parte de los jóvenes más brillantes de la EMBO. 2017-11-03. Red Leonardo. es. 2019-11-03.
  13. Web site: Guadalupe Sabio: "la presencia minoritaria de mujeres en la ciencia es algo que se está empezando a corregir ahora". López. Pepa. 2019-07-19. Trendencias. es. 2019-11-03.
  14. Web site: Las científicas españolas incrementan su presencia en Wikipedia - Grupo L'Oréal. www.loreal.es. es-ES. 2019-11-03.
  15. Web site: Guadalupe Sabio, 2012 FPdGi Scientific Research Award. en.fpdgi.org. 2019-11-03.
  16. Web site: Guadalupe Sabio: 'La base del éxito es saber fracasar'. 2014-03-27. ELMUNDO. es. 2019-11-03.
  17. Web site: La pacense Guadalupe Sabio, premiada por una investigación sobre la obesidad. 2018-09-13. Hoy. es. 2019-11-03.
  18. Web site: Nueve mujeres sobresalientes y una recién nacida, ganadoras de los Premios MAS. 2019-10-22. MAS: Mujeres a seguir. 2019-11-03.
  19. Web site: Guadalupe Sabio, Ana Pastor, Olga Felip, Joana Pastrana, Sonia Díez y Mar González, galardonadas en la VI Premios MAS. 2019-10-23. La Vanguardia. 2019-11-03.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Guadalupe Sabio".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.